Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The BALANCE Model: What CMSs GLP-1 Model Means for Eli Lilly and the Future of Obesity Treatment Decoding a pharmaceutical payment model that could reshape access to obesity treatmentor crumble under its own complexity At 4pm on December 23rd, while most of us were winding down for the holidays, CMS announced the BALANCE Model: their request for applications from GLP-1 manufacturers willing to negotiate directly with the federal government for expanded Medicare and Medicaid coverage
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
Hammoutene, A
Sherly Soleiman, MD, Founder & Medical Director, a Board-Certified Physician with 25+ years of medical experience and training
Our services are currently available in all 50 U.S
US$ 29.32
US$ 24.54
US$ 29.77
US$ 26.40
